Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Martin

Showing results (31-40 of 226) with videos related to

Pageof 23
Sort By:
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1993
Differential fibrinolytic properties of the recombinant plasminogen activator BM 06.022 in human plasma and blood clot systems in vitroU Martin, G Sponer, K Strein
International Journal of Hematology|October 1, 1992
Hirudin and sulotroban improve coronary blood flow after reperfusion induced by the novel recombinant plasminogen activator BM 06.022 in a canine model of coronary artery thrombosisU Martin, G Sponer, K Strein
Klinische Wochenschrift|May 15, 1977
[Follow-up studies after removal of arterial occlusions by streptokinase treatment. A 6-year retrospective study including 67 patients (author's transl)]M Martin, U Martin, H Auel
Die Medizinische Welt|October 28, 1972
[Inhibition of thrombocyte adhesiveness in blood by Bencyclan. Experimental and clinical findings]M Martin, G Schäfer, U Martin
Journal of Cardiovascular Pharmacology|March 1, 1993
Rapid reversal of canine thromboembolic pulmonary hypertension by bolus injection of the novel recombinant plasminogen activator BM 06.022U Martin, G Sponer, K Strein
Nature Immunology|January 20, 2016
Interleukin 33 is a guardian of barriers and a local alarminNikolas T Martin, Michael U Martin
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Influence of hepatic and renal failure on pharmacokinetic properties of the novel recombinant plasminogen activator BM 06.022 in ratsU Martin, G Sponer, K Strein
British Journal of Pharmacology|May 1, 1996
Comparison of desulfatohirudin (REVASC) and heparin as adjuncts to thrombolytic therapy with reteplase in a canine model of coronary thrombosisU Martin, L Dörge, S Fischer
Dysphagia|January 1, 1992
Meeting the oral health needs of institutionalized elderlyK U Martin, J O Martin
International Archives of Allergy and Applied Immunology|January 1, 1982
Phagocytosis of mast cell granules by mononuclear phagocytes, neutrophils and eosinophils during anaphylaxisM Baggiolini, U Horisberger, U Martin
Pageof 23

Showing results (31-40 of 226) with videos related to

Sort By:
Pageof 23
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 1, 1993
Differential fibrinolytic properties of the recombinant plasminogen activator BM 06.022 in human plasma and blood clot systems in vitroU Martin, G Sponer, K Strein
International Journal of Hematology|October 1, 1992
Hirudin and sulotroban improve coronary blood flow after reperfusion induced by the novel recombinant plasminogen activator BM 06.022 in a canine model of coronary artery thrombosisU Martin, G Sponer, K Strein
Klinische Wochenschrift|May 15, 1977
[Follow-up studies after removal of arterial occlusions by streptokinase treatment. A 6-year retrospective study including 67 patients (author's transl)]M Martin, U Martin, H Auel
Die Medizinische Welt|October 28, 1972
[Inhibition of thrombocyte adhesiveness in blood by Bencyclan. Experimental and clinical findings]M Martin, G Schäfer, U Martin
Journal of Cardiovascular Pharmacology|March 1, 1993
Rapid reversal of canine thromboembolic pulmonary hypertension by bolus injection of the novel recombinant plasminogen activator BM 06.022U Martin, G Sponer, K Strein
Nature Immunology|January 20, 2016
Interleukin 33 is a guardian of barriers and a local alarminNikolas T Martin, Michael U Martin
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Influence of hepatic and renal failure on pharmacokinetic properties of the novel recombinant plasminogen activator BM 06.022 in ratsU Martin, G Sponer, K Strein
British Journal of Pharmacology|May 1, 1996
Comparison of desulfatohirudin (REVASC) and heparin as adjuncts to thrombolytic therapy with reteplase in a canine model of coronary thrombosisU Martin, L Dörge, S Fischer
Dysphagia|January 1, 1992
Meeting the oral health needs of institutionalized elderlyK U Martin, J O Martin
International Archives of Allergy and Applied Immunology|January 1, 1982
Phagocytosis of mast cell granules by mononuclear phagocytes, neutrophils and eosinophils during anaphylaxisM Baggiolini, U Horisberger, U Martin
Pageof 23